FCOMV
KNTE

Foresite Capital Opportunity Management V’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History

Foresite Capital Opportunity Management V’s Portfolio KNTE Stock Details KNTE Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$3.49M Hold
291,667
– – 10.46% 5
2022
Q2 		$3.68M Hold
291,667
– – 9.27% 5
2022
Q1 		$3.28M Hold
291,667
– – 4.6% 8
2021
Q4 		$5.17M Buy
+291,667
New +$5.17M 3.46% 7